# Medical Marijuana Use and Workplace Policy in Healthcare: Florida Insights

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/medical-marijuana-workplace-policy-healthcare-florida/
> **Published:** 2026-04-24T08:19:14-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:13:06-04:00
> **Clinical Summary:** Explore medical marijuana workplace policy challenges faced by healthcare workers in Florida, highlighting clinical integration and provider education gaps.

---

✦ New

 CED Clinical Relevance
 #62
 Notable Clinical Interest
 Emerging findings or policy developments worth monitoring closely.

MedicalMental HealthSafetyPolicy

 Clinical Summary
 

# Clinical Summary

This Reddit discussion among Florida healthcare workers reveals practical challenges and perspectives on [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) in clinical practice, including concerns about integration into conventional healthcare systems, knowledge gaps among providers, and workplace policy conflicts. The thread highlights that despite Florida’s medical cannabis program authorization, many healthcare professionals lack formal training in cannabinoid pharmacology, patient counseling, and appropriate clinical applications, creating a gap between regulatory approval and evidence-based clinical practice. Contributors discuss the tension between patients seeking cannabis recommendations and institutional resistance or lack of provider familiarity, suggesting that medical marijuana remains underintegrated into standard clinical workflows despite legal availability. These observations underscore that regulatory approval alone does not ensure clinician competence or institutional readiness to safely recommend and monitor [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in patient populations. For clinicians, this discussion reinforces the importance of seeking continuing education on cannabinoid pharmacology and developing evidence-based protocols for patient assessment and monitoring when recommending medical cannabis, regardless of institutional barriers or personal comfort levels.

 Clinical Perspective
 
 

This Reddit discussion captures the real-world tensions healthcare workers face when navigating cannabis use in states with medical marijuana programs, particularly regarding employment policies, professional licensing, and workplace drug screening. While Florida’s medical marijuana framework permits patient access, many healthcare employers maintain blanket prohibitions on cannabis use by staff due to federal Schedule I status, insurance requirements, and concerns about impairment during clinical duties, creating a disconnect between state law and institutional policy that can affect recruitment and retention in the healthcare workforce. Clinicians should recognize that their patients may be using medical cannabis legally while their colleagues face employment consequences for the same substance, highlighting the regulatory complexity that persists despite growing state-level legalization. The absence of objective impairment testing comparable to breathalyzers for alcohol, combined with variable cannabis metabolism and workplace safety concerns in high-stakes clinical environments, justifies institutional caution but also warrants transparency with employees about specific policies and their rationale. Healthcare organizations should

 

 

💬 Join the Conversation

 

Have a question about how this applies to your situation?
 [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

 

Want to discuss this topic with other patients and caregivers?
 [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/mental-health/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Medical+%3Cb%3Emarijuana%3C%2Fb%3E+as+someone+working+in+healthcare+industry+%3A+r%2Fflorida+-+Reddit+%40drcaplan&url=https%3A%2F%2Fwww.reddit.com%2Fr%2Fflorida%2Fcomments%2F1rnc8sv%2Fmedical_marijuana_as_someone_working_in%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.reddit.com%2Fr%2Fflorida%2Fcomments%2F1rnc8sv%2Fmedical_marijuana_as_someone_working_in%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Medical+%3Cb%3Emarijuana%3C%2Fb%3E+as+someone+working+in+healthcare+industry+%3A+r%2Fflorida+-+Reddit+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.reddit.com%2Fr%2Fflorida%2Fcomments%2F1rnc8sv%2Fmedical_marijuana_as_someone_working_in%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

 Related Articles
 
- [The marijuana of my youth is long gone. I wish someone had told me – CNN](https://cedclinic.com/cannabis-potency-clinical-relevance-modern-thc-safety/)
- [Trump advisor says someone is “holding up” cannabis rescheduling (Newsletter: April 10, 2026)](https://cedclinic.com/2026-cannabis-rescheduling-news-trump-advisor-delay/)
- [CED Digest: 230 Items — March 18, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/)

📰 Source: [https://www.reddit.com/r/florida/comments/1rnc8sv/medical_marijuana_as_someone_working_in/](https://www.reddit.com/r/florida/comments/1rnc8sv/medical_marijuana_as_someone_working_in/)

 Further Reading
 CED Clinic Blog[Cannabinoids and Chronic Pain: 2025 Evidence Review](https://cedclinic.com/cannabinoids-chronic-pain-clinical-outcomes-2025/)
 Research Digest[Research Digest: 10 Recent Studies – April 22, 2026](https://cedclinic.com/recent-cannabinoid-clinical-research-april-2026/)
 Cannabis Policy WireCED Regulatory Digest, Since Last Digest, 1 items

 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 
 Physician-Led, Whole-Person Care
 A doctor who takes the time to truly understand you.
 Personal care that starts with listening and is guided by experience and ingenuity.
 
 Health, Longevity, Wellness
 One-on-One Cannabis Guidance
 Metabolic Balance
 
 
 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 
 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Medical marijuana rescheduling is legally puzzling but still a ‘huge win’ for patients](https://cedclinic.com/medical-cannabis-rescheduling-legal-shift-patient-impact/)

Explore the complexities of medical marijuana rescheduling and its impact on patient access and legal frameworks.

[Read More](https://cedclinic.com/medical-cannabis-rescheduling-legal-shift-patient-impact/)

[Justice Department reclassifies state-licensed medical marijuana as a less dangerous drug](https://cedclinic.com/justice-department-medical-marijuana-reclassification/)

Learn about the recent reclassification of medical marijuana and what it means for healthcare providers and patients.

[Learn More](https://cedclinic.com/justice-department-medical-marijuana-reclassification/)

[The legal cannabis boom has a science problem – GreenState](https://cedclinic.com/cannabis-legalization-research-impact/)

Understand the scientific challenges facing the legal cannabis industry and implications for clinical practice.

[Explore Article](https://cedclinic.com/cannabis-legalization-research-impact/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
